Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ea5c646cccd552734c446d8ceab5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e4d9402a27f239a799491673cf80694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e6e9d2f4ecf359656d624b31acb1c4d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate |
2008-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135d388a9a7bd4331387065f14b579d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc2fbd4328808db1571a9b506c4e2aa |
publicationDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008152052-A1 |
titleOfInvention |
Intradermal influenza vaccine |
abstract |
The invention relates to virosome-based influenza vaccines for the manufacture of medicaments that are administered intradermally in humans. The invention provides (trivalent) compositions comprising low doses of hemagglutinin (HA) antigen in a virosomal preparation that fulfill the immune response standards with respect to seroconversion rates, GMT-fold increase and protection rates, for use in vaccination set-ups. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590078-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011262309-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11523988-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011151723-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224571-B2 |
priorityDate |
2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |